Dr. Manmeet Ahluwalia is a neurologist and neuro-oncologist serving as Chief of Solid Tumor Medical Oncology, Deputy Director, and Chief Scientific Officer at Miami Cancer Institute, Baptist Health South Florida (Miami, FL). He specializes in primary brain tumors and brain metastases, with a strong focus on immunotherapy, precision medicine, and clinical trials in neuro-oncology. Dr. Ahluwalia has authored more than 250 publications and has built world-class clinical trials programs, including prior efforts at Cleveland Clinic. He chairs national neuro-oncology initiatives within the U.S. National Cancer Institute’s cooperative group framework and leads multidisciplinary strategies to advance research and patient care. His contributions have been recognized with numerous honors, including Fellowship in the American Society of Clinical Oncology, the American Brain Tumor Consortium Career Development Award, Crain’s 40 Under 40, and the Ellis Island Medal of Honor. He is an active collaborator and leader in regional and national oncology groups, committed to improving outcomes for patients with brain tumors.
Chief Scientific Officer
Medical School
2001
Residency
2006
Fellowship
2009